Effects of solid-state fermentation product of yeast supplementation on liver and intestinal health, and resistance of common carp () against spring viraemia carp virus.

This study aimed to investigate the effects of solid-state fermentation products of yeast (SFPY) on liver and intestinal health and disease resistance of common carp (). A total of 200 common carp with an initial average weight of 2.55 ± 0.004 g were divided into 5 groups (4 replications per group and 10 fish per replication), and were fed with one of five diets, including a control diet and 4 diets supplemented with 2‰ (Y2), 3‰ (Y3), 4‰ (Y4), or 5‰ (Y5) SFPY, respectively, for 8 weeks. Results indicated that, the addition of SFPY to the diet of common carp did not affect the growth performance or survival rate of fish ( = 0.253). Interestingly, with the addition of SFPY, the triacylglycerol (TAG) content of the liver presented a linear decreasing tendency ( = 0.004), with significantly decreased in Y4 and Y5 groups ( = 0.035) compared with control. Serum lipopolysaccharide (LPS) content and diamine oxidase (DAO) activity presented a negative linear relationship with the addition of SFPY ( = 0.015,  = 0.030), while serum lipopolysaccharide binding protein (LBP) content first decreased and then increased ( < 0.001). The total antioxidant capacity (T-AOC) in the intestine of fish increased continuously with increasing SFPY supplementation ( = 0.026), reaching the highest level in Y5 group. The villus height in all experimental groups were significantly higher than that in the control group ( < 0.001). Furthermore, compared to the control, adding 3‰ SFPY to the control diet of common carp significantly increased the relative abundance of Fusobacteria ( = 0.018) and decreased that of Proteobacteria ( = 0.039) at phylum level, and increased the relative abundance of (= 0.018) and decreased that of ( = 0.013) at genus level. Compared with the control, the relative mRNA expression level of spring viraemia of carp virus N protein ( ) in the kidney was lower than that of the control group without significance and bottomed out in Y4 group ( = 0.138). In conclusion, dietary SFPY enhanced the SVCV resistance capacity of common carp by improving liver and intestinal health and modulating the gut microbiota. Thus, SFPY is a potential feed additive to be used in aquaculture to reduce the huge economic loss of common carp due to SVCV disease. Based on liver TAG content and intestinal villus height, the optimal addition level of SFPY was 3.02‰ and 2.72‰, respectively.